Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IQ motif containing protein K (IQCK) is a member of a large family of proteins possessing the IQ motif, a sequence of about 25 amino acids that binds calmodulin in a calcium-independent manner to modulate calcium signaling[1]. IQCK is expressed in a cell-type specific manner in the mouse brain, notably in neurons, astrocytes, and oligodendrocytes but not microglia[4]. Expression appears to be regulated by cell physiology, developmental stage, and stress signals. IQ motif-containing proteins impact calmodulin-dependent signaling pathways, potentially influencing processes such as cytoskeletal organization or signal transduction[1][4]. Recent research has implicated IQCK as a novel genetic risk factor for Alzheimer's disease, supporting its potential use as a disease biomarker and possible future therapeutic target[4]. However, its precise physiological and pathological roles, as well as interactions with drugs, remain to be fully elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IQ motif containing protein K (IQCK).